- Home
- ESEA vs OSUR Comparison
ESEA vs OSUR Comparison
Compare ESEA & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESEA | OSUR |
|---|---|---|
| Founded | 2005 | 2000 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 481.2M | 207.2M |
| IPO Year | 2005 | 2000 |
Fundamental Metrics
Financial Performance| Metric | ESEA | OSUR |
|---|---|---|
| Price | $64.86 | $3.58 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 2 |
| Target Price | ★ $62.00 | $3.00 |
| AVG Volume (30 Days) | 46.5K | ★ 596.2K |
| Earning Date | 06-17-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.24% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $167,064,000.00 |
| Revenue This Year | $1.74 | $4.48 |
| Revenue Next Year | $1.07 | $7.76 |
| P/E Ratio | $3.39 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $37.52 | $2.08 |
| 52 Week High | $78.76 | $3.76 |
Technical Indicators
Market Signals| Indicator | ESEA | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 42.01 | 73.38 |
| Support Level | $60.48 | $2.87 |
| Resistance Level | $65.17 | N/A |
| Average True Range (ATR) | 4.14 | 0.17 |
| MACD | -0.49 | 0.05 |
| Stochastic Oscillator | 6.10 | 97.97 |
Price Performance
Historical ComparisonAbout ESEA Euroseas Ltd. (Marshall Islands)
Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes, providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is principally engaged in the development, manufacture, marketing, sale and distribution of (i) diagnostics products, and (ii) sample management solutions. It develops products and services that support diagnostic testing and healthcare data analysis, with a focus on improving access to healthcare. The company derives its revenues from the sale of diagnostics products and sample management solutions. Geographically, it generates the maximum revenue from the United States.